Investment Rating - The report does not explicitly state an investment rating for the company Core Insights - The performance of the company is significantly influenced by the cyclical nature of the industry, similar to 2021 [1] - The recent surge in stock price is attributed to the excitement around "brain-computer interface" technologies and solid-state battery materials, although these have not yet contributed to financial results [30] - The company has shown signs of stabilizing its performance since 2024, primarily due to its investments in copper and cobalt resources in the Democratic Republic of Congo [10][18] Summary by Sections Financial Performance - As of January 5, 2026, the company reported a revenue of 6.001 billion, a year-on-year decline of 1.79%, but a net profit of 415 million, a significant increase of 182.45% [5] - The company's net profit has fluctuated over the years, with a peak of 562 million in 2021, a drop to 86 million in 2022, a loss of 28 million in 2023, and a recovery to 157 million in 2024 [6] - The increase in net profit in 2025 is attributed to the expansion of copper and cobalt resource operations, which have benefited from rising metal prices [10][18] Business Structure and Strategy - The company has diversified its business from ceramics to include carbon materials, lithium battery materials, and strategic resources like copper and cobalt [15] - In 2024, the copper and cobalt segments contributed 31.62% of revenue, with a gross margin of 32.93%, and by the first half of 2025, this contribution increased to 47.44% [15] - The company is focusing on solid-state battery materials, including single-walled carbon nanotubes, which are critical for overcoming challenges in solid-state battery production [19][21] Market Position and Future Outlook - The company is positioned to benefit from the solid-state battery market, with ongoing research and development in key materials [19][26] - The domestic market for single-walled carbon nanotubes is competitive, with the company being one of the leaders alongside Tianai Technology [23] - A recent signal of potential concern is the reduction of shares by the controlling shareholder, which may indicate a strategic shift or market timing [26]

联系人：冯光亮 光伏设备 执业证书编号：S0740521120002 Email：wangfang02@zts.com.cn 执业证书编号：S0740521120001 Email：yangxu01@zts.com.cn Email：fenggl@zts.com.cn 基本状况 总股本(百万股) 461.16 流通股本(百万股) 461.16 市价(元) 75.71 市值(百万元) 34,914.22 流通市值(百万元) 34,914.22 微导纳米（688147.SH） 证券研究报告/公司深度报告 2026 年 01 月 08 日 | 评级： | 增持（首次） | 公司盈利预测及估值 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 指标 | | 2023A | 2024A | 2025E | 2026E | 2027E | | 分析师：王芳 | | 营业收入（百万元） | | 1,680 | 2,700 | 2,619 | 2,692 | 3,721 | | | | 增长率 yoy% | | 145% | ...

Investment Rating - The investment rating for China Pacific Insurance (601601) is "Buy" (maintained) [5] Core Views - China Pacific Insurance, as the only listed insurance company backed by the Shanghai State-owned Assets Supervision and Administration Commission, is expected to benefit from its deepening transformation and forward-looking layout in the Web3 sector, potentially leading to a dual boost in performance and valuation [1] - The strategic importance of the insurance industry is increasing, with significant expectations for China Pacific Insurance's transformation in life insurance and support from the Shanghai State-owned Assets [2] - The company is positioned to experience strong growth in new business value (NBV) due to its ongoing transformation initiatives and strategic support from its major shareholder [3] - The forward-looking layout in the Web3 sector is anticipated to drive valuation increases for China Pacific Insurance [4] Summary by Relevant Sections Super Expectation Points - The strategic importance of the insurance industry has been recognized, with the release of new policies promoting high-quality transformation [2] - The risk of interest spread losses is easing, with a continuous reduction in liability costs and an expected increase in investment returns from the equity market [3] - The implementation of the "North Star Plan" is expected to significantly boost NBV, with a notable increase in the agent workforce and a substantial rise in NBV from the bancassurance channel [3] - The strategic support from the Shanghai State-owned Assets is crucial for the company's high-quality development [3] - China Pacific Insurance's proactive engagement in the Web3 sector is expected to enhance its market position [4] Financial Forecasts - Projected net profit growth rates for 2025E-2027E are 6.2%, 21.2%, and 29.4% respectively, with corresponding PEV ratios of 0.77x, 0.71x, and 0.65x [9] - The target price based on a 0.9x PEV for 2026 is set at ¥60.85, indicating a potential upside of 27% [11] Financial Summary - For 2025E, the expected operating revenue is ¥419,626 million, with a net profit of ¥47,769 million [11] - The company is expected to maintain a strong performance with a significant increase in NBV and investment income [11]

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected stock price increase of over 20% relative to the benchmark index within the next six months [6][14]. Core Insights - The company has successfully completed the design and mass production of consumer-grade steel shell batteries, which offer higher flexibility and efficiency compared to traditional polymer soft-pack batteries. This innovation is expected to enhance applications in consumer electronics such as smartphones and smartwatches [3]. - The company is expanding its market reach into emerging consumer electronics, including smart wearables and drones, and has achieved significant growth in these sectors. Notably, it will supply high-end smartwatch batteries to Samsung using a Cell+Pack supply model by 2025 [4]. - The company is focusing on advanced technologies, including the development of silicon anode batteries and sodium-ion batteries, which are expected to enhance its competitive edge in the battery market. The silicon anode batteries have achieved a high energy density of 900Wh/L, while sodium-ion batteries are being developed for stable power supply in low-temperature scenarios [5]. Financial Projections - Revenue projections for the company are as follows: 2025 at 144 billion yuan, 2026 at 200 billion yuan, and 2027 at 239 billion yuan. Corresponding net profits are expected to be 6.4 billion yuan, 16 billion yuan, and 21 billion yuan respectively [6][10]. - The company is projected to achieve a revenue growth rate of 24.38% in 2025, 38.98% in 2026, and 19.66% in 2027, with net profit growth rates of 48.98%, 154.73%, and 29.01% for the same years [10][11]. - The earnings per share (EPS) are forecasted to be 0.57 yuan in 2025, 1.44 yuan in 2026, and 1.86 yuan in 2027, with a decreasing price-to-earnings (P/E) ratio from 56.82 in 2024 to 11.61 in 2027 [10][11]. Company Overview - The latest closing price of the company's stock is 21.60 yuan, with a total market capitalization of 245 billion yuan. The company has a debt-to-asset ratio of 65.3% and a current P/E ratio of 56.84 [2]. - The largest shareholder is Zhuhai Prida Investment Co., Ltd., which indicates a significant backing for the company's operations and growth strategies [2].

拟收购及安盾消防科技，协同升级驱动新增长 ——公司点评报告 工程机械 国际扩张成效显著》2025-10-15 2、《2024 年业绩稳健增长，订单高 增成长可期》2025-04-26 执业证书编号：S0740519080001 Email：wangke03@zts.com.cn | 基本状况 | | | --- | --- | | 总股本(百万股) | 1,009.04 | | 流通股本(百万股) | 1,003.72 | | 市价(元) | 6.97 | | 市值(百万元) | 7,033.03 | | 流通市值(百万元) | 6,995.94 | 海伦哲（300201.SZ） 证券研究报告/公司点评报告 2026 年 01 月 08 日 | 买入（维持） 评级： | | 公司盈利预测及估值 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 指标 | | | | 2023A | 2024A | 2025E | 2026E | 2027E | | 分析师：王可 | | 营业收入（百万元） | | 1,352 | 1, ...

势头 [Table_ReportDate] 亿帆医药(002019)公司简评报告 | 2026.01.08 核心观点 [Table_Title] 多元化方式补充创新药管线，核心品种延续快速增长 | 最新收盘价（元） | 12.77 | | --- | --- | | 一年内最高/最低价（元） | 16.66/9.88 | | 市盈率（当前） | 38.13 | | 市净率（当前） | 1.76 | | 总股本（亿股） | 12.16 | | 总市值（亿元） | 155.33 | 资料来源：聚源数据 相关研究 请务必仔细阅读本报告最后部分的重要法律声明 [Table_Summary] [Table_Chart] 市场指数走势（最近 1 年） -0.5 0 0.5 1 8-Jan 21-Mar 1-Jun 12-Aug 23-Oct 3-Jan 亿帆医药 沪深300 资料来源：聚源数据 [Table_Rank] 评级： 增持 [Table_Authors] 王斌 医药行业首席分析师 SAC 执证编号：S0110522030002 wangbin3@sczq.com.cn 电话：010-81152644 [Tabl ...

证券研究报告 公司研究 [Table_ReportType] 点评报告 [Table_StockAndRank] 卓易信息(688258.SH) 请阅读最后一页免责声明及信息披露 http://www.cindasc.com 1 [Table_OtherReport] ➢ 低门槛开发，全面提升开发效率。SnapDevelop 致力于降低企业应用 开发门槛，通过可视化设计与 AI 辅助协同，帮助开发团队显著减少手 工编码工作量，缩短开发周期。1）相较于低代码平台来说，产品直接 生成用户可以维护的代码，用户可根据自己的实际情况对模块或者功能 进行扩展和修改。2）内嵌 AI 编程助手，目前支持 Deepseek、通义千 问、豆包等主流 AI 模型，可自动生成 50%-80%的代码，实现 3-5 倍的 效率提升。 ➢ 面向云原生应用开发，鸿蒙专项能力支持。与传统 IDE（微软的 VisualStudio、JetBrains 的 IntelliJIDEA 等）相比，SnapDevelop 在云 原生领域具有明显优势，主要支持.NET 平台的云原生开发，拥有专门 为云原生开发设计的开发组件和模板。同时 SnapDevel ...

2025 年 12 月 27 日，公司发布《关于对外投资暨在境外设立合资工厂的 公告》，海安集团及其全资子公司海安俄罗斯有限公司、旗舰股份公司及先 锋股份公司等四方主体于 2025 年 12 月 26 日签署了一份《投资意向协议》， 海安集团与旗舰股份公司拟对先锋股份公司增资，并以先锋股份公司（俄罗 斯海安持股 51%，旗舰股份公司持股 49%）为主体在俄罗斯建设巨型全钢工 程机械子午线轮胎工厂，预计总投资规模不超过 539.90 亿卢布（折合约 43.19 亿元人民币）,本次建设为一期工程，设计年产能为 1.05 万条/年。 事件点评 100.00/57.77 0.35/1.86 大型矿卡用轮胎极具特色，具备高壁垒、定制化、长导入周期的特点。 巨胎的壁垒主要体现在技术壁垒和客户壁垒两个方面，其一技术壁垒，巨胎 的生产制造及配方具备极高的壁垒，目前国内大尺寸巨胎的使用寿命与海外 巨头企业存在明显差距，且尺寸越大差距越大；其二客户壁垒，矿卡在运行 过程中轮胎一旦出现问题，可能会对造价高昂的矿卡造成损坏，严重影响矿 山运营导致损失，因此进入矿山企业巨胎供应商需要长周期的验证过程。巨 胎也是一款定制化的产品，根据应 ...

Investment Rating - The report gives a "Buy" rating for the company, marking its first coverage [1][7]. Core Views - The company is positioned as a comprehensive stationery supplier and office service provider, with traditional core businesses including writing tools, student stationery, and office supplies. New businesses include the ToB retail e-commerce platform and retail stores [6][10]. - The company is expected to leverage IP and international expansion as new growth drivers, enhancing product pricing and market reach [6][10]. Summary by Sections 1. Company Overview - The company has a stable traditional core business while accelerating exploration of new business opportunities [10]. - Revenue and profit have shown steady growth, with a projected revenue of 24.2 billion yuan in 2024, reflecting a CAGR of 23% from 2014 to 2024 [14][16]. 2. Core Business - The company focuses on enhancing product value through IP, leading to continuous price increases. The sales volume of traditional core products has faced pressure, but the average price has increased due to product structure optimization and IP collaboration [26][30]. - The company has established a unique "Morning Light Partner Pyramid" marketing model, enhancing its competitive edge through extensive retail networks [32]. 3. Office Direct Sales and Retail Stores - The office direct sales segment, represented by the company’s ToB platform, has shown steady revenue growth, achieving 13.8 billion yuan in 2024, with a CAGR of 30% from 2019 to 2024 [39][45]. - The retail store segment, including brands like "Jiumu Zawushang" and "Morning Light Life Museum," has expanded significantly, with 741 stores by 2024, reflecting a 20% year-on-year increase [47][51]. 4. Profit Forecast and Valuation - The company is expected to achieve revenues of 25.2 billion yuan in 2025, with a growth rate of 4% year-on-year, and 30.4 billion yuan by 2027, maintaining a similar growth trajectory [58]. - The report anticipates improvements in gross margins due to IP enhancements, projecting a gross margin of 18.5% in 2025 [59].

Investment Rating - The report initiates coverage with a "Buy" rating for the company [8] Core Insights - The company is a leading domestic manufacturer of wet paper-based friction plates, essential components for automatic transmissions in passenger vehicles, successfully breaking the long-standing monopoly of foreign companies [5][6] - In the first three quarters of 2025, the company achieved revenue of 326 million yuan, a year-on-year increase of 68.9%, and a net profit attributable to shareholders of 107 million yuan, up 131.2% year-on-year [5] - The company is expanding its production capacity, with an expected capacity of 80 million plates per year by the end of 2025, and further growth to 97 million plates per year in 2026 [6] - The company is also venturing into the electronic limited-slip differential (ELSD) market, which is projected to grow significantly, with a global market size expected to reach 11.14 billion USD by 2032 [7] Financial Performance - Revenue projections for 2025, 2026, and 2027 are 421 million yuan, 554 million yuan, and 733 million yuan respectively, with corresponding net profits of 138 million yuan, 181 million yuan, and 238 million yuan [10][11] - The company’s gross margin is expected to improve from 43.7% in 2024 to 47.9% in 2027, indicating strong profitability [13] - The price-to-earnings (P/E) ratio is projected to decrease from 56.17 in 2024 to 19.16 in 2027, suggesting an attractive valuation over time [10][13]